Takeda Biopharmaceuticals India Private Limited, formerly known as Baxalta Bioscience India Pvt. Ltd., has recently been certified as a Great Place To Work® in India from March 2023 to March 2024. The global biopharmaceutical company, which focuses on R&D in Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI), is dedicated to creating an engaging and supportive work environment for its employees.
The Great Place To Work® Institute, a worldwide authority on workplace culture, has spent over three decades researching the qualities that define exceptional workplaces. These include strong leadership, a consistent employee experience, and stable financial performance. In India, the Institute collaborates with over 1400 organizations annually across 22 industries to develop High-Trust, High-Performance Cultures.
Takeda’s employees work tirelessly to enhance patients’ quality of life and collaborate with healthcare partners in nearly 80 countries and regions. The Great Place to Work® certification serves as a testament to Takeda India’s commitment to cultivating a culture where employees can contribute to the company’s mission and values while growing professionally.
